Copyright: ©Author(s) 2026.
World J Clin Oncol. Jun 24, 2026; 17(6): 121169
Published online Jun 24, 2026. doi: 10.5306/wjco.121169
Published online Jun 24, 2026. doi: 10.5306/wjco.121169
Table 1 The circulating levels of tumor markers and cytokines in the pathogenesis of lung cancer
| Tumor markers and cytokines | Circulating levels |
| CEA | Increased level |
| SCC | Not yet reported |
| CK19 | Increased level |
| TNF-α | Increased level |
| GM-CSF | Increased level |
| IFN-γ | Increased level |
| IL-1 | Increased level |
| IL-2 | Increased level |
| IL-4 | Increased level |
| IL-6 | Increased level |
| IL-8 | Increased level |
| IL-10 | Increased level |
| MCP-1 | Increased level |
| NSE | Increased level |
- Citation: Tariq M, Sattar A, Khalid A, Azam M, Mehmood M, Hafeez R, Rafaqat S. Role of tumor markers and cytokines in the pathogenesis of lung cancer. World J Clin Oncol 2026; 17(6): 121169
- URL: https://www.wjgnet.com/2218-4333/full/v17/i6/121169.htm
- DOI: https://dx.doi.org/10.5306/wjco.121169